相关实验视频

Updated: Sep 16, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

与米托坦结合使用德法提尼布可能是人类上皮层癌的有效治疗方法

Henriett Butz^1,2,3,4, Lőrinc Pongor^3,5, Lilla Krokker⁴

¹Department of Molecular Genetics and the National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.

International journal of molecular sciences

|July 12, 2025

概括

与米托坦结合的德法提尼布在治疗上腺皮癌 (ACC) 方面表现有前途. 这种新型组合疗法在临床前模型中有效降低了瘤生长和转移,没有观察到毒性.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
基因组学就是基因组学.

背景情况:

皮上腺癌 (ACC) 是一种具有有限治疗选择的侵袭性恶性瘤.
米托坦是FDA批准的唯一用于ACC的全身疗法,但其长期疗效仍有争议.
药物重新定位为发现新型癌症治疗方法提供了一个具有成本效益的策略.

研究的目的:

评估德法提尼布与米托坦结合用于上腺皮癌治疗的疗效.
调查ACC中潜在的分子机制,包括FAK信号,在ACC.
评估mitotane-defactinib组合的安全性和药物相互作用.

主要方法:

在ACC细胞系中使用了功能测定,转录基因分析和2D/3D细胞培养.
生物打印组织和异种移植在体内模拟了ACC.
分析了来自人类ACC和正常上腺样本的基因组数据.
核磁共振评估了药物相互作用,而体内研究评估了毒性.

主要成果:

焦点粘附激酶 (FAK) 信号在ACC上调,与生存率差相关.
德法提尼布单独和与米托坦一起在体外显示出抗瘤活性.
在体内,这种组合显著降低了瘤体积和巨度转移,并增加了缩.
没有观察到显著的毒性或药物相互作用.

结论:

FAK信号是上腺皮癌中潜在的治疗点.
德法提尼布和米托坦的组合显示出在ACC治疗中具有显著的临床前前景.
这种新的组合值得进一步对上腺皮层癌进行临床研究.

关键词:

3D模型是3D模型.上皮层癌症上皮层癌症德法提尼布的使用方法毒品的重新使用.焦点粘附信号的信号.有针对性的治疗.

更多相关视频

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...